Development of Synthnode, An Implantable Biomaterial Platform for in vivo CAR T Therapy
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Persistence Therapeutics, Inc.
Award Date
Award Amount
650,000
Program Name
Strategic Growth Loan
Program Category
Business Financing
Principal Investigator
Charles Buchen
Fiscal Year
2026
Region
Research Triangle
Project Description:
Persistence Therapeutics, Inc, of Chapel Hill received $650,000 to support development of Synthnode, which is an implant that generates CAR T cells in the body, offering an in vivo therapy that is better, faster, and cheaper than existing options.